Ari Rosenberg, MD, University of Chicago Medical Center, Chicago, IL, discusses the Phase I trial (NCT01847326) of nab-paclitaxel-based induction therapy followed by nab-paclitaxel-based chemotherapy and re-irradiation for patients with previously-treated head and neck cancer. The
[More]